The Bioss Blog

News, updates, and analysis from the world of research. Interested in having your work with Bioss' products featured on the site? Email for more information.

Be sure to follow us on Twitter and Facebook for regular updates.

Bioss Named "Key Antibody Company to Watch" by CiteAb

With a growing share of product citations from around the world, Bioss was named a key company to watch in the antibody market by CiteAb, the citation-ranked antibody search engine and database.

For the last 5+ years, Bioss has seen rapid growth in the share of citations, reaching its highest mark to date — 0.31% for 2016.

Bioss continues to expand its catalog of more than 11,000 primary products with 15 available conjugations while making investments in more robust testing and validation techniques, including a new effort to provide knockout validation on select products.

Data and image provided courtesy of CiteAb. To read the full analysis, follow this link.

Bioss Antibodies

Posted by Bioss Antibodies